Skip to main content
Log in

Analysis of familial hypoalphalipoproteinemia syndromes

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Familial hypoalphalipoproteinemias (HA) are a heterogenous group of disorders characterized by various degrees of HDL deficiency. Differential diagnosis involves clinical and biochemical evaluation after intervention designed to correct known secondary causes of low HDL. Two specific HAs are discussed in this report: 1. primary isolated HA (PIHA) is a poorly characterized entity with an apparent autosomal dominant transmission and distinct abnormalities in the structure and function of HDL. 2. Lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes are caused by a number of different genetic defects that lead to at least two distinct clinical presentations i.e. familial LCAT deficiency and fish eye disease. PIHA is an example of a genetic disorder whose diagnosis would greatly be improved by the availability of molecular diagnostic tests. Conversely, the effect of the genetic heterogeneity of LCAT deficiency syndromes on diagnosis is best overcome by utilizing existing biochemical measurement of LCAT activity and the plasma cholesterol esterification rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eisenberg S: High density lipoprotein metabolism. J Lipid Res 25: 1017–1058, 1984

    Google Scholar 

  2. Fruchart J-C, Theret N, Barbaras R, Puchois P, Ailhaud G: Apo A-containing lipoprotein particles. Physiological role, quantification and clinical significance. In: A Lars (ed.) Disorders of HDL. Smith-Gordon Publishers, London, 1990, pp 71–75

    Google Scholar 

  3. Nichols AV, Blanche PJ, Gong EL: Gradient gel electrophoresis of human plasma high density lipoproteins. In: L Lewis, J Opplt (eds.) CRC Handbook of electrophoresis, Vol III. Boca Raton, FL: CRC Press, 1983, pp 29–47

    Google Scholar 

  4. Cheung MG, Albers JJ: Characterization of lipoprotein particles isolated by immunoaffinity chromatography: Particles containing A-1 and A-II and particles containing A-I but no A-II. J Biol Chem 259, 12201–12209, 1984

    Google Scholar 

  5. Carlson LA: Disorders of HDL. (ed.) Smith-Gordon Publishers, London, 1990

    Google Scholar 

  6. Castelli W, Doyle JT, Gordon T et al.: HDL cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotyping study. Circulation 55: 767–772, 1977

    CAS  PubMed  Google Scholar 

  7. Gordon T, Castelli WP, Hjortland MC et al.: High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 62: 707–714, 1977

    Article  CAS  PubMed  Google Scholar 

  8. Goldbourt U, Medalie JH: High density lipoprotein cholesterol and incidence of coronary heart disease: The Israeli ischaemic heart disease study. Am J Epidemiol 109: 296–308, 1979

    Google Scholar 

  9. Castelli WP, Garrison RJ, Wilson PWF et al.: Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 256: 2835–2838, 1986

    Google Scholar 

  10. Keyes A, Karvonen JM, Punsar S et al.: HDL serum cholesterol and 24-year mortality of men in Finland. Int J Epidemiol 13: 428–435, 1984

    Google Scholar 

  11. Assman G. Schulte H: PROCAM Trial, Pansientia Verlag, Zurich, 1986

    Google Scholar 

  12. Frick MH, Elo O, Haapa K et al.: Helsinki heart study: Primaryprevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 317: 1237–1245, 1987

    Google Scholar 

  13. Vergani C, Bertalle A: Familial hypoalphalipoproteinemia. Clin Chem Acta 114: 45–52, 1983

    Google Scholar 

  14. Norum RA, Lakier JB, Goldstein S et al.: Familial deficiency of apolipoprotein A-I and C-III and precocious coronary artery disease. N Engl J Med 306: 1519, 1982

    Google Scholar 

  15. Schaefer EJ, Ordovas JM, Law SW et al.: Familial apolipoprotein A-I and CIII deficiency, variant II. J Lipid Res 26: 1089–1101, 1985

    Google Scholar 

  16. Gjone E, Norum KR, Glomset JA: Familial LCAT deficiency. In: JB Stanbury, JB Wyngaarden, DS Fredrickson (eds.) The metabolic basis of inherited disease. McGraw-Hill, New York, 1978, pp 589–603

    Google Scholar 

  17. Frohlich J, McLeod R: Lecithin: Cholesterol acyltransferase deficiency syndromes. Adv Exp Biol Med 201: 181–194, 1986

    Google Scholar 

  18. Carlson LA: Fish-eye disease: A new familial condition with massive corneal opacities and dyslipoproteinemia. Eur J Clin Invest 12: 41–53, 1982

    Google Scholar 

  19. Frohlich J, Hoag G, McLeod R et al.: Hypoalphalipoproteinemia resembling fish eye disease. Acta Med Scand 221: 291–298, 1987

    Google Scholar 

  20. Funke H, von Eckardstein A, Pritchard PH, Karas M, Albers JJ, Assmann G: A frameshift mutation in the apolipoprotein A-I gene causes HDL deficiency, partial LCAT deficiency, and corneal opacities: A disorder which is biochemically distinct from fish eye disease. J Clin Invest 87: 371–376, 1991

    Google Scholar 

  21. Norum RA, Alaupovic P: J Lipid Res 1992 (in press)

  22. Herbert PN, Assmann G, Gotto Jr AM, Fredrickson DS: Familial lipoprotein deficiency: Abetalipoproteinemia, hypobetalipoproteinemia, and Tangier disease. In: JB Stanbury, JB Wyngaarden, DS Fredrickson, JL Goldstein, MS Brown (eds.) The metabolic basis of inherited disease. New York, McGraw-Hill, 1983, pp 589–621

    Google Scholar 

  23. Frohlich J, Pritchard PH, Sparks DL, Westerlund J: Primary isolated hypo-α-lipoproteinemia: A distinct familial lipoprotein abnormality: In: L Carlson (ed.) Disorders of High Density Lipoprotein. Smith Gordon Ltd, Lon. 1990, pp 177–184

    Google Scholar 

  24. Sparks DL, Frohlich J, Lacko AG, Pritchard PH: The relationship between cholesteryl ester transfer activity and high density lipoprotein composition in hyperlipidemic patients. Atherosclerosis 77: 183–191, 1989

    Google Scholar 

  25. Sparks DL, Pritchard PH: The effect of the neutral lipid core of recombinant high density lipoproteins on lecithin: cholesterol acyltransferease activity. Biochem Cell Biol 67: 358–364, 1989

    Google Scholar 

  26. Sparks DL, Pritchard PH: The effect of lipid and apo protein content of high density lipoprotein on the transfer of cholesteryl esters from cholesteryl ester transfer protein. J Lipid Res 30: 1491–1498, 1989

    Google Scholar 

  27. Sparks DL, Pritchard PH: Abnormal HDL composition results in defective transport of cholesteryl ester. Circulation 80 (Suppl 2): 454, 1989

    Google Scholar 

  28. Sparks DL, Frohlich J, Pritchard PH: Hyperlipidemia and cholesterol transport. Am Heart J 122: 601–607, 1991

    Google Scholar 

  29. Ordovas JM, Schaefer EJ, Salem D et al.: Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Eng J Med 314: 617–7, 1986

    Google Scholar 

  30. Kastelein JJP, Hayden MR, Langlois S: Familial hypoalphalipoproteinemia (Abstr.) 8th Intl Symposium on Atherosclerosis. Rome, October 9–13, 443, 1988

  31. Taramelli R, Pontoglio M, Candiani G et al.: Lecithin cholesterolacyl transferase deficiency: Molecular analysis of a mutated allele. Human Gen 85: 195–199, 1991

    Google Scholar 

  32. Maeda E, Naka Y, Matozaki T, Sakuma M, Akanuma Y, Yoshino G, Kasuga M: Lecithin-cholesterol acyltransferase (LCAT) deficiency with a missense mutation in exon 6 of the LCAT gene. Biochem Biophys Res Commun 178: 460–466, 1991

    Google Scholar 

  33. Gotoda T, Yamada N, Murase T et al.: Differential phenotypic expression by three mutant alleles in familial lecithin: cholesterol acyl transferase deficiency. Lancet 338: 778–781, 1991

    Google Scholar 

  34. Funcke H, von Eckardstein A, Pritchard PH, Albers JJ, Kastelein JJP, Assmann G: The molecular defect causing Fish Eye Disease. Proc Natl Acad Sci 88: 4855–4859, 1991

    Google Scholar 

  35. Magil A, Chase W, Frohlich J: Unusual renal biopsy in a patient with familial lecithin: cholesterol acyltransferase deficiency. Human Path 13: 183–185, 1982

    Google Scholar 

  36. Godin DV, Gray G, Frohlich J: Erythrocyte membrane alterations in lecithin: cholesterol acyltransferase deficiency. Scand J Clin Lab Invest 38 (Suppl. 150): 162–167, 1978

    Google Scholar 

  37. Carlson LA, Holmquist L: Paradoxical esterification of plasma cholesterol in fish eye disease. Acta Med Scand 217: 491–498, 1985

    Google Scholar 

  38. Forte T, Carlson LA:Electron microscopic structure of serum lipoproteins from patients with fish eye disease. Arterosclerosis 4: 130–136, 1984

    Google Scholar 

  39. Von Eckardstein A, Funke H, Henke A, Altand K, Benninghoven A, Assmann G: Apolipoprotein A-I variants. J Clin Invest 84: 1722–1730, 1989

    Google Scholar 

  40. Frohlich J, McLeod R, Pritchard PH: Plasma lipoprotein abnormalities in heterozygotes for familial lecithin: cholesterol acyltransferase deficiency. Metabolism 37: 3–8, 1988

    Google Scholar 

  41. Brunzell JD: Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: CR Scriver, AL Beaudet, WS Sly, D Valle (eds.) The Inherited Basis of Metabolic Disease. 1989, pp 1165–1180

  42. Breslow JL: Familial Disorders of High Density. In: CR Scriver, AL Beaudet, WS Sly, D Valle (eds.) The Inherited Basis of Metabolic Disease. 1989, pp 1251–1266

  43. Moorjani S, personal communication

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frohlich, J., Pritchard, P.H. Analysis of familial hypoalphalipoproteinemia syndromes. Mol Cell Biochem 113, 141–149 (1992). https://doi.org/10.1007/BF00231534

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00231534

Key words

Navigation